Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and Older

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 1000 participants.

Also called NCT07828730

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose screening
Phase
Not applicable
Enrolled
  • 1,000 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07828730
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07828730. Randomized; no masking; primary purpose screening. Start 2026-12 (anticipated); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sparrow App Guided Evaluation (SAGE) Vanguard Trial for Aortic Stenosis in Adults Aged Seventy and Older
Acronym
SAGE-AS
Condition
Moderate or Severe Aortic Stenosis
Intervention (Device)
Stethophone
Lead sponsor
Sunnybrook Health Sciences Centre (class: other)
Collaborator
KMH Cardiology and Diagnostic Centres (class: other)
Collaborator
Sparrow Acoustics Inc. (class: industry)
Collaborator
Ontario Health (class: not stated)
Collaborator
Canadian Cardiovascular Society (class: other)
Collaborator
Edwards life sciences (class: not stated)
Collaborator
Medtronic (class: industry)

Record details

Record id
cardio:ct-nct07828730
Content hash
65bbed1c23c5775fd8c3fdbedba2d65ef0fd7a2c6a7d92f9bf1cb7709113c03e